Residual renal function: Considerations on its importance and preservation in dialysis patients

Seminars in Dialysis

Volumn 17, Issue 3, 2004, Pages 196-201

  Chandna, Shahid M ^a   Farrington, Ken ^a  

^a LISTER HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

AMINOGLYCOSIDE; BIOMATERIAL; BUFFER; CONTRAST MEDIUM; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; HEMOGLOBIN; NONSTEROID ANTIINFLAMMATORY AGENT; PHOSPHATE; POTASSIUM; URATE; WATER;

BIOCOMPATIBILITY; DIALYSIS; DIETARY INTAKE; FLUID INTAKE; HEMOGLOBIN DETERMINATION; HUMAN; HYPOALBUMINEMIA; KIDNEY CLEARANCE; KIDNEY FUNCTION; NUTRITIONAL STATUS; PERITONEAL DIALYSIS; PHOSPHATE URINE LEVEL; POTASSIUM URINE LEVEL; PREGNANCY; PROTEINURIA; QUALITY OF LIFE; RENOVASCULAR HYPERTENSION; REVIEW; SURVIVAL RATE; TREATMENT OUTCOME; URIC ACID URINE LEVEL;

HUMANS; KIDNEY; KIDNEY FAILURE, CHRONIC; PERITONEAL DIALYSIS; RENAL DIALYSIS;

EID: 3042613724     PISSN: 08940959     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.0894-0959.2004.17306.x     Document Type: Review

References (105)

1. Tattersall JE, Doyle S, Greenwood RN, Farrington K: Kinetic modelling and underdialysis in CAPD patients. Nephrol Dial Transplant 8:535-538, 1993
2. Gao H, Lew SQ, Ronco C, Mishkin GJ, Bosch JP: The impact of residual renal function and total body water volume on achieving adequate dialysis in CAPD. J Nephrol 12:184-189, 1999
3. Burkart JM, Satko SG: Incremental initiation of dialysis: one center's experience over a two-year period. Perit Dial Int 20:418-422, 2000
4. Caravaca F, Arrobas M, Dominguez C: Influence of residual renal function on dietary protein and caloric intake in patients on incremental peritoneal dialysis. Perit Dial Int 19:350-356, 1999
5. Nolph KD: Rationale for early incremental dialysis with continuous ambulatory peritoneal dialysis. Nephrol Dial Transplant 13(suppl 6):117-119, 1998
6. Morduchowicz G, Winkler J, Zabludowski JR, Boner G: Effects of residual renal function in haemodialysis patients. Int Urol Nephrol 26:125-131, 1994
7. II.3 Haemodialysis dose and residual renal function (Kr). Nephrol Dial Transplant 17(suppl 7):24, 2002
8. Montini G, Amici G, Milan S, Mussap M, Naturale M, Ratsch IM, Ammenti A, Sorino P, Verrina E, Andreetta B, Zacchello G: Middle molecule and small protein removal in children on peritoneal dialysis. Kidney Int 61:1153-1159, 2002
9. Lopez-Menchero R, Miguel A, Garcia-Ramon R, Perez-Contreras J, Girbes V: Importance of residual renal function in continuous ambulatory peritoneal dialysis: its influence on different parameters of renal replacement treatment. Nephron 83:219-225, 1999
10. McCarthy JT, Williams AW, Johnson WJ: Serum beta 2-microglobulin concentration in dialysis patients: importance of intrinsic renal function [see comments]. J Lab Clin Med 123:495-505, 1994
11. Mistry CD, O'Donoghue DJ, Nelson S, Gokal R, Ballardie FW: Kinetic and clinical studies of beta 2-microglobulin in continuous ambulatory peritoneal dialysis: influence of renal and enhanced peritoneal clearances using glucose polymer. Nephrol Dial Transplant 5:513-519, 1990
12. Duranti E, Sasdelli M: Serum B2 microglobulin (B2M) in CAPD. Adv Perit Dial 5:195-199, 1989
13. Blumberg A, Burgi W: Behavior of beta 2-microglobulin in patients with chronic renal failure undergoing hemodialysis, hemodiafiltration and continuous ambulatory peritoneal dialysis (CAPD). Clin Nephrol 27:245-249, 1987
14. Montenegro J, Martinez I, Saracho R, Gonzalez R: Beta 2 microglobulin in CAPD. Adv Perit Dial 8:369-372, 1992
15. Amici G, Virga G, Da Rin G, Grandesso S, Vianello A, Gatti P, Bocci C: Serum beta-2-microglobulin level and residual renal function in peritoneal dialysis. Nephron 65:469-471, 1993
16. Canaud B, Assounga A, Flavier JL, Slingeneyer A, Aznar R, Robinet-Levy M, Mion C: Beta-2 microglobulin serum levels in maintenance dialysis. What does it mean? ASAIO Trans 34:923-929, 1988
17. Copley JB, Lindberg JS: Nontransplant therapy for dialysis-related amyloidosis. Semin Dial 14:94-98, 2001
18. Page DE, Knoll GA, Cheung V: The relationship between residual renal function, protein catabolic rate, and phosphate and magnesium levels in peritoneal dialysis patients. Adv Perit Dial 18:189-191, 2002
19. Altmann P, Butter KC, Plowman D, Chaput de Saintonge DM, Cunningham J, Marsh FP: Residual renal function in hemodialysis patients may protect against hyperalbuminemia. Kidney Int 32:710-713, 1987
20. Suda T, Hiroshige K, Ohta T, Watanabe Y, Iwamoto M, Kanegae K, Ohtani A, Nakashima Y: The contribution of residual renal function to overall nutritional status in chronic haemodialysis patients. Nephrol Dial Transplant 15:396-401, 2000
21. Wang AY, Wang M, Woo J, Law MC, Chow KM, Li PK, Lui SF, Sanderson JE: A novel association between residual renal function and left ventricular hypertrophy in peritoneal dialysis patients. Kidney Int 62:639-647, 2002
22. Erkan E, Moritz M, Kaskel F: Impact of residual renal function in children on hemodialysis. Pediatr Nephrol 16:858-861, 2001
23. Aguilera A, Codoceo R, Bajo MA, Diez JJ, del Peso G, Pavone M, Ortiz J, Valdez J, Cirugeda A, Fernandez-Perpen A, Sanchez-Tomero JA, Selgas R: Helicobacter pylori infection: a new cause of anorexia in peritoneal dialysis patients. Perit Dial Int 21(suppl 3):S152-S156, 2001
24. Scanziani R, Dozio B, Bonforte G, Surian M: Residual renal function and nutritional parameters in CAPD. Adv Perit Dial 11:106-109, 1995
25. Wang AY, Sea MM, Ip R, Law MC, Chow KM, Lui SF, Li PK, Woo J: Independent effects of residual renal function and dialysis adequacy on actual dietary protein, calorie, and other nutrient intake in patients on continuous ambulatory peritoneal dialysis. J Am Soc Nephrol 12:2450-2457, 2001
26. Wang AY, Sea MM, Ip R, Law MC, Chow KM, Lui SF, Li PK, Woo J: Independent effects of residual renal function and dialysis adequacy on dietary micronutrient intakes in patients receiving continuous ambulatory peritoneal dialysis. Am J Clin Nutr 76:569-576, 2002
27. Merkus MP, Jager KJ, Dekker FW, Boeschoten EW, Stevens P, Krediet RT: Quality of life in patients on chronic dialysis: self-assessment 3 months after the start of treatment. The Necosad Study Group. Am J Kidney Dis 29:584-592, 1997
28. Amoah E, Arab H: Pregnancy in a hemodialysis patient with no residual renal function. Am J Kidney Dis 17:585-587, 1991
29. Gafter U, Peleg D, Korzets A, Zevin D, Landman J, Goldman J, Levi J: Successful pregnancies in women on regular hemodialysis treatment. Isr J Med Sci 26:266-270, 1990
30. Reister F, Reister B, Heyl W, Riehl J, Schroder W, Mann H, Rath W: Dialysis and pregnancy - a case report and review of the literature. Ren Fail 21:533-539, 1999
31. Successful pregnancies in women treated by dialysis and kidney transplantation. Report from the Registration Committee of the European Dialysis and Transplant Association. Br J Obstet Gynaecol 87:839-845, 1980
32. Abbassi H, Salah-Eddine A, Jersifi H, Samouh N, Moutabarrik A, Niang A: [Chronic renal failure and pregnancy]. Gynecol Obstet Fertil 29:106-115, 2001
33. Chung SH, Heimburger O, Stenvinkel P, Qureshi AR, Lindholm B: Association between residual renal function, inflammation and patient survival in new peritoneal dialysis patients. Nephrol Dial Transplant 18:590-597, 2003
34. Bargman JM, Thorpe KE, Churchill DN: Relative contribution of residual renal function and peritoneal clearance to adequacy of dialysis: a reanalysis of the CANUSA study. J Am Soc Nephrol 12:2158-2162, 2001
35. Rocco MV, Frankenfield DL, Prowant B, Frederick P, Flanigan MJ: Risk factors for early mortality in U.S. peritoneal dialysis patients: impact of residual renal function. Perit Dial Int 22:371-379, 2002
36. Shemin D, Bostom AG, Lambert C, Hill C, Kitsen J, Kliger AS: Residual renal function in a large cohort of peritoneal dialysis patients: change over time, impact on mortality and nutrition. Perit Dial Int 20:439-444, 2000
37. Ates K, Nergizoglu G, Keven K, Sen A, Kutlay S, Erturk S, Duman N, Karatan O, Ertug AE: Effect of fluid and sodium removal on mortality in peritoneal dialysis patients. Kidney Int 60:767-776, 2001
38. Shemin D, Bostom AG, Laliberty P, Dworkin LD: Residual renal function and mortality risk in hemodialysis patients. Am J Kidney Dis 38:85-90, 2001
39. Bhatla B, Moore HL, Nolph KD: Modification of creatinine clearance by estimation of residual urinary creatinine and urea clearance in CAPD patients. Adv Perit Dial 11:101-105, 1995
40. Milutinovic J, Cutler RE, Hoover P, Meijsen B, Scribner BH: Measurement of residual glomerular filtration rate in the patient receiving repetitive hemodialysis. Kidney Int 8:185-190, 1975
41. Caravaca F, Arrobas M, Pizarro JL, Sanchez-Casado E: Uraemic symptoms, nutritional status and renal function in pre-dialysis end-stage renal failure patients. Nephrol Dial Transplant 16:776-782, 2001
42. van Olden RW, Krediet RT, Struijk DG, Arisz L: Measurement of residual renal function in patients treated with continuous ambulatory peritoneal dialysis. J Am Soc Nephrol 7:745-750, 1996
43. van Olden RW, van Acker BA, Koomen GC, Krediet RT, Arisz L: Time course of inulin and creatinine clearance in the interval between two haemodialysis treatments. Nephrol Dial Transplant 10:2274-2280, 1995
44. Swan SK, Halstenson CE, Kasiske BL, Collins AJ: Determination of residual renal function with iohexol clearance in hemodialysis patients. Kidney Int 49:232-235, 1996
45. Sterner G, Frennby B, Mansson S, Ohlsson A, Prutz KG, Almen T: Assessing residual renal function and efficiency of hemodialysis - an application for urographic contrast media. Nephron 85:324-333, 2000
46. Sacamay TE, Bolton WK: Use of iohexol to quantify hemodialysis delivered and residual renal function: technical note. Kidney Int 54:986-991, 1998
47. Rottembourg J, Issad B, Allouache M, Jacobs C: Recovery of renal function in patients treated by CAPD. Adv Perit Dial 5:63-66, 1989
48. Wang T, Ye RG, Zhen ZH, Li HQ, Mai WY: Influence of peritoneal dialysis on the progression of chronic renal failure. Adv Perit Dial 11:139-141, 1995
49. Berlanga JR, Marron B, Reyero A, Caramelo C, Ortiz A: Peritoneal dialysis retardation of progression of advanced renal failure. Perit Dial Int 22:239-242, 2002
50. McKane W, Chandna SM, Tattersall JE, Greenwood RN, Farrington K: Identical decline of residual renal function in high-flux biocompatible hemodialysis and CAPD. Kidney Int 61:256-265, 2002
51. Hiroshige K, Yuu K, Soejima M, Takasugi M, Kuroiwa A: Rapid decline of residual renal function in patients on automated peritoneal dialysis. Perit Dial Int 16:307-315, 1996
52. Hufnagel G, Michel C, Queffeulou G, Skhiri H, Damieri H, Mignon F: The influence of automated peritoneal dialysis on the decrease in residual renal function. Nephrol Dial Transplant 14:1224-1228, 1999
53. Van Biesen W, Veys N, Vanholder R, Lameire N: The role of APD in the improvement of outcomes in an ESRD program. Semin Dial 15:422-426, 2002
54. Shin SK, Noh H, Kang SW, Seo BJ, Lee IH, Song HY, Choi KH, Ha SK, Lee HY, Han DS: Risk factors influencing the decline of residual renal function in continuous ambulatory peritoneal dialysis patients. Perit Dial Int 19:138-142, 1999
55. Shemin D, Maaz D, St. Pierre D, Kahn SI, Chazan JA: Effect of aminoglycoside use on residual renal function in peritoneal dialysis patients. Am J Kidney Dis 34:14-20, 1999
56. Singhal MK, Bhaskaran S, Vidgen E, Bargman JM, Vas SI, Oreopoulos DG: Rate of decline of residual renal function in patients on continuous peritoneal dialysis and factors affecting it. Perit Dial Int 20:429-438, 2000
57. Van Stone JC: The effect of dialyzer membrane and etiology of kidney disease on the preservation of residual renal function in chronic hemodialysis patients. ASAIO J 41:M713-M716, 1995
58. Rottembourg J, Issad B, Gallego JL, Degoulet P, Aime F, Gueffaf B, Legrain M: Evolution of residual renal function in patients undergoing maintenance haemodialysis or continuous ambulatory peritoneal dialysis. Proc Eur Dial Transplant Assoc 19:397-403, 1983
59. Lysaght MJ, Vonesh EF, Gotch F, Ibels L, Keen M, Lindholm B, Nolph KD, Pollock CA, Prowant B, Farrell PC: The influence of dialysis treatment modality on the decline of remaining renal function. ASAIO Trans 37:598-604, 1991
60. Moist LM, Port FK, Orzol SM, Young EW, Ostbye T, Wolfe RA, Hulbert-Shearon T, Jones CA, Bloembergen WE: Predictors of loss of residual renal function among new dialysis patients. J Am Soc Nephrol 11:556-564, 2000
61. Misra M, Vonesh E, Van Stone JC, Moore HL, Prowant B, Nolph KD: Effect of cause and time of dropout on the residual GFR: a comparative analysis of the decline of GFR on dialysis. Kidney Int 59:754-763, 2001
62. McCarthy JT, Jenson BM, Squillace DP, Williams AW: Improved preservation of residual renal function in chronic hemodialysis patients using polysulfone dialyzers. Am J Kidney Dis 29:576-583, 1997
63. Hartmann J, Fricke H, Schiffl H: Biocompatible membranes preserve residual renal function in patients undergoing regular hemodialysis. Am J Kidney Dis 30:366-373, 1997
64. Caramelo C, Alcazar R, Gallar P, Teruel JL, Velo M, Ortega O, Galera A, Da Silva M: Choice of dialysis membrane does not influence the outcome of residual renal function in haemodialysis patients. Nephrol Dial Transplant 9:675-677, 1994
65. Hakim RM, Wingard RL, Husni L, Parker RA, Parker TF III: The effect of membrane biocompatibility on plasma beta 2-microglobulin levels in chronic hemodialysis patients. J Am Soc Nephrol 7:472-478, 1996
66. Hakim RM: Clinical implications of hemodialysis membrane biocompatibility. Kidney Int 44:484-494, 1993
67. Pertosa G, Grandaliano G, Gesualdo L, Schena FP: Clinical relevance of cytokine production in hemodialysis. Kidney Int Suppl 76:S104-S111, 2000
68. Smeby LC, Wideroe TE, Balstad T, Jorstad S: Biocompatibility aspects of cellophane, cellulose acetate, polyacrylonitrile, polysulfone and polycarbonate hemodialyzers. Blood Purif 4:93-101, 1986
69. Stannat S, Bahlmann J, Kiessling D, Koch KM, Deicher H, Peter HH: Complement activation during hemodialysis. Comparison of polysulfone and cuprophane membranes. Contrib Nephrol 46:102-108, 1985
70. Schindler R, Lonnemann G, Schaffer J, Shaldon S, Koch KM, Krautzig S: The effect of ultrafiltered dialysate on the cellular content of interleukin-1 receptor antagonist in patients on chronic hemodialysis. Nephron 68:229-233, 1994
71. Schiffl H, Lang SM, Fischer R: Ultrapure dialysis fluid slows loss of residual renal function in new dialysis patients. Nephrol Dial Transplant 17:1814-1818, 2002
72. La Greca G, Feriani M, Bragantini L, Petrosino L, Santoro A, Altieri P: Effects of acetate and bicarbonate dialysate on vascular stability: a prospective multicenter study. Int J Artif Organs 10:157-162, 1987
73. Fischbach M, Terzic J, Menouer S, Soulami K, Dangelser C, Helmstetter A, Gehant F: Effects of automated peritoneal dialysis on residual daily urinary volume in children. Adv Perit Dial 17:269-273, 2001
74. Lang SM, Bergner A, Topfer M, Schiffl H: Preservation of residual renal function in dialysis patients: effects of dialysis-technique-related factors. Perit Dial Int 21:52-51, 2001
75. Jansen MA, Hart AA, Korevaar JC, Dekker FW, Boeschoten EW, Krediet RT: Predictors of the rate of decline of residual renal function in incident dialysis patients. Kidney Int 62:1046-1053, 2002
76. Keshaviah PR, Emerson PF, Nolph KD: Timely initiation of dialysis: a urea kinetic approach. Am J Kidney Dis 33:344-348, 1999
77. Gunal AI, Duman S, Ozkahya M, Toz H, Asci G, Akcicek F, Basci A: Strict volume control normalizes hypertension in peritoneal dialysis patients. Am J Kidney Dis 37:588-593, 2001
78. Medcalf JF, Harris KP, Walls J: Role of diuretics in the preservation of residual renal function in patients on continuous ambulatory peritoneal dialysis. Kidney Int 59:1128-1133, 2001
79. van Olden RW, van Meyel JJ, Gerlag PG: Acute and long-term effects of therapy with high-dose furosemide in chronic hemodialysis patients. Am J Nephrol 12:351-356, 1992
80. Krediet RT, Douma CE, van Olden RW, Ho-dac-Pannekeet MM, Struijk DG: Augmenting solute clearance in peritoneal dialysis. Kidney Int 54:2218-2225, 1998
81. van de Ven PJ, Beutler JJ, Kaatee R, Beek FJ, Mali WP, Koomans HA: Angiotensin converting enzyme inhibitor-induced renal dysfunction in atherosclerotic renovascular disease. Kidney Int 53:986-993, 1998
82. Toto RD, Mitchell HC, Lee HC, Milam C, Pettinger WA: Reversible renal insufficiency due to angiotensin converting enzyme inhibitors in hypertensive nephrosclerosis. Ann Intern Med 115:513-519, 1991
83. Kalra PA, Kumwenda M, MacDowall P, Roland MO: Questionnaire study and audit of use of angiotensin converting enzyme inhibitor and monitoring in general practice: the need for guidelines to prevent renal failure. BMJ 318:234-237, 1999
84. Devoy MA, Tomson CR, Edmunds ME, Feehally J, Walls J: Deterioration in renal function associated with angiotensin converting enzyme inhibitor therapy is not always reversible. J Intern Med 232:493-498, 1992
85. Mailloux LU, Napolitano B, Bellucci AG, Vernace M, Wilkes BM, Mossey RT: Renal vascular disease causing end-stage renal disease, incidence, clinical correlates, and outcomes: a 20-year clinical experience. Am J Kidney Dis 24:622-629, 1994
86. Appel RG, Bleyer AJ, Reavis S, Hansen KJ: Renovascular disease in older patients beginning renal replacement therapy. Kidney Int 48:171-176, 1995
87. Dunn MJ, Scharschmidt L, Zambraski E: Mechanisms of the nephrotoxicity of non-steroidal anti-inflammatory drugs. Arch Toxicol Suppl 7:328-337, 1984
88. Nephrotoxicity of non-steroidal anti-inflammatory drugs. Lancet 344:515-518, 1994
89. Gambaro G, Perazella MA: Adverse renal effects of anti-inflammatory agents: evaluation of selective and nonselective cyclooxygenase inhibitors. J Intern Med 253:643-652, 2003
90. McCullough PA, Wolyn R, Rocher LL, Levin RN, O'Neill WW: Acute renal failure after coronary intervention: incidence, risk factors, and relationship to mortality. Am J Med 103:368-375, 1997
91. Parfrey PS, Griffiths SM, Barrett BJ, Paul MD, Genge M, Withers J, Farid N, McManamon PJ: Contrast material-induced renal failure in patients with diabetes mellitus, renal insufficiency, or both. A prospective controlled study. N Engl J Med 320:143 -149, 1989
92. Lautin EM, Freeman NJ, Schoenfeld AH, Bakal CW, Haramati N, Friedman AC, Lautin JL, Braha S, Kadish EG, Sprayregen S: Radiocontrast-associated renal dysfunction: incidence and risk factors. AJR Am J Roentgenol 157:49-58, 1991
93. Manske CL, Sprafka JM, Strony JT, Wang Y: Contrast nephropathy in azotemic diabetic patients undergoing coronary angiography. Am J Med 89:615-620, 1990
94. Barrett BJ, Parfrey PS, Vavasour HM, McDonald J, Kent G, Hefferton D, O'Dea F, Stone E, Reddy R, McManamon PJ: Contrast nephropathy in patients with impaired renal function: high versus low osmolar media. Kidney Int 41:1274-1279, 1992
95. Weinrauch LA, Healy RW, Leland OS Jr, Goldstein HH, Kassissieh SD, Libertino JA, Takacs FJ, D'Elia JA: Coronary angiography and acute renal failure in diabetic azotemic nephropathy. Ann Intern Med 86:56-59, 1977
96. Tepel MGM, Schwarzfeld C, Laufer U, Liermann D, Zidek W: Prevention of radiographic-contrast-agent-induced reductions in renal function by acetylcysteine. N Engl J Med 343:180-184, 2000
97. Shyu KG, Cheng JJ, Kuan P: Acetylcysteine protects against acute renal damage in patients with abnormal renal function undergoing a coronary procedure. J Am Coll Cardiol 40:1383-1388, 2002
98. Aspelin P, Aubry P, Fransson SG, Strasser R, Willenbrock R, Berg KJ: Nephrotoxic effects in high-risk patients undergoing angiography. N Engl J Med 348:491-499, 2003
99. Tzamaloukas AH, Murata GH, Malhotra D: Renal clearances in continuous ambulatory peritoneal dialysis: differences between diabetic and non-diabetic subjects. Int J Artif Organs 24:203-207, 2001
100. Iest CG, Vanholder RC, Ringoir SM: Loss of residual renal function in patients on regular haemodialysis. Int J Artif Organs 12:159-164, 1989
101. Ganote CE, Philipsborn DS, Chen E, Carone FA: Acute calcium nephrotoxicity. An electron microscopical and semiquantitative light microscopical study. Arch Pathol 99:650-657, 1975
102. Nussbaum SR: Pathophysiology and management of severe hypercalcemia. Endocrinol Metab Clin N Am 22:343-362, 1993
103. Chen HH, Chen YC, Yeh JC: Renoprotection following treatment of secondary hyperparathyroidism with percutaneous ethanol injection in pre-dialysis patients. Nephron 92:105-110, 2002
104. Traynor JP, Simpson K, Geddes CC, Deighan CJ, Fox JG: Early initiation of dialysis fails to prolong survival in patients with end-stage renal failure. J Am Soc Nephrol 13:2125-2132, 2002
105. Ahmad S, Babb AL, Milutinovic J, Scribner BH: Effect of residual renal function on minimum dialysis requirements. Proc Eur Dial Transplant Assoc 16:107-114, 1979